{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:40:05Z","timestamp":1793090405171,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:00:00Z","timestamp":1552608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001821","name":"Vienna Science and Technology Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001821","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.neuropharm.2019.03.015","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T13:06:10Z","timestamp":1552655170000},"page":"107572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Rescue by 4-phenylbutyrate of several misfolded creatine transporter-1 variants linked to the creatine transporter deficiency syndrome"],"prefix":"10.1016","volume":"161","author":[{"given":"Ali","family":"El-Kasaby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameya","family":"Kasture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Koban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matej","family":"Hotka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz M.M.","family":"Asjad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Kubista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9398-1765","authenticated-orcid":false,"given":"Michael","family":"Freissmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Sucic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2019.03.015_bib2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/syn.20280","article-title":"Exocytotic release of creatine in rat brain","volume":"60","author":"Almeida","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2019.03.015_bib3","first-page":"20","article-title":"Creatine transporter deficiency: novel mutations and functional studies","volume":"8","author":"Ardon","year":"2016","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib5","doi-asserted-by":"crossref","first-page":"19250","DOI":"10.1074\/jbc.M117.797092","article-title":"Pharmacochaperoning in a drosophila model system rescues human dopamine transporter variants associated with infantile\/juvenile parkinsonism","volume":"292","author":"Asjad","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib6","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1093\/hmg\/ddw252","article-title":"A mouse model for creatine transporter deficiency reveals early onset cognitive impairment and neuropathology associated with brain aging","volume":"25","author":"Baroncelli","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib9","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ymgme.2011.12.022","article-title":"Creatine Transporter Research, Group, Jakobs C, Salomons GS. Detection of variants in SLC6A8 and functional analysis of unclassified missense variants","volume":"105","author":"Betsalel","year":"2012","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib10","series-title":"Creatine and Creatine Kinase in Health and Disease","first-page":"99","article-title":"Functional insights into the creatine transporter","author":"Christie","year":"2007"},{"key":"10.1016\/j.neuropharm.2019.03.015_bib10a","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1529\/biophysj.103.038422","article-title":"Automatic and quantitative measurement of protein-protein colocalization in live cells","volume":"86","author":"Costes","year":"2004","journal-title":"Biophys. J."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib11","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/S0021-9258(17)37831-6","article-title":"Different accessibilities in chromatin to histone acetylase","volume":"254","author":"Cousens","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.gene.2015.04.011","article-title":"Estimated carrier frequency of creatine transporter deficiency in females in the general population using functional characterization of novel missense variants in the SLC6A8 gene","volume":"565","author":"DesRoches","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.neuropharm.2019.03.015_bib13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1471-4159.2010.06957.x","article-title":"Functional and immunocytochemical characterization of the creatine transporter in rat hippocampal neurons","volume":"115","author":"Dodd","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/blood.V84.1.339.339","article-title":"Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate","volume":"84","author":"Dover","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.neuropharm.2019.03.015_bib15","doi-asserted-by":"crossref","first-page":"28987","DOI":"10.1074\/jbc.M114.595090","article-title":"A cytosolic relay of heat shock proteins HSP70-1A and HSP90\u03b2 monitors the folding trajectory of the serotonin transporter","volume":"289","author":"El-Kasaby","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib16","series-title":"Handbook of Experimental Pharmacology: Targetting Trafficking in Drug Development","first-page":"249","article-title":"SLC6 transporter folding diseases and pharmacochaperoning","author":"Freissmuth","year":"2018"},{"key":"10.1016\/j.neuropharm.2019.03.015_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1254\/jphs.12194FP","article-title":"Effects of the chemical chaperone 4-phenylbutylate on the function of the serotonin transporter (SERT) expressed in COS-7 cells","volume":"122","author":"Fujiwara","year":"2013","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib18","doi-asserted-by":"crossref","first-page":"C937","DOI":"10.1152\/ajpcell.00219.2010","article-title":"Dynamic interplay of excitatory and inhibitory coupling modes of neuronal L-type calcium channels","volume":"300","author":"Geier","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150098","article-title":"Functional rescue of trafficking-impaired ABCB4 mutants by chemical chaperones","volume":"11","author":"Gordo-Gilart","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2019.03.015_bib21","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1086\/340092","article-title":"X-linked mental retardation with seizures and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28","volume":"70","author":"Hahn","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pediatrneurol.2016.10.007","article-title":"Variable white matter atrophy and intellectual development in a family with X-linked creatine transporter deficiency despite genotypic homogeneity","volume":"67","author":"Heussinger","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0026-895X(25)08696-1","article-title":"Thiophosphorylation of the G protein \u03b2-subunit in human platelet membranes: evidence against a direct phosphate transfer reaction to G\u03b1 subunits","volume":"49","author":"Hohenegger","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1471-4159.2006.04440.x","article-title":"Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone","volume":"101","author":"Inden","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib25","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bbamem.2013.11.002","article-title":"Differential functional rescue of Lys(513) and Lys(516) processing mutants of MRP1 (ABCC1) by chemical chaperones reveals different domain-domain interactions of the transporter","volume":"1838","author":"Iram","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2019.03.015_bib26","doi-asserted-by":"crossref","first-page":"20876","DOI":"10.1074\/jbc.M116.737551","article-title":"Functional rescue of a misfolded Drosophila melanogaster dopamine transporter mutant associated with a sleepless phenotype by pharmacological chaperones","volume":"291","author":"Kasture","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biocel.2017.09.004","article-title":"An unfolding story: small molecules remedy misfolded monoamine transporters","volume":"92","author":"Kasture","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib29","doi-asserted-by":"crossref","first-page":"13263","DOI":"10.1074\/jbc.M115.641357","article-title":"A salt bridge linking the first intracellular loop with the C terminus facilitates the folding of the serotonin transporter","volume":"290","author":"Koban","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.biocel.2015.01.015","article-title":"The therapeutic effects of 4-phenylbutyric acid in maintaining proteostasis","volume":"61","author":"Kolb","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vascn.2012.08.001","article-title":"Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders","volume":"66","author":"Konsoula","year":"2012","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.neuropharm.2019.03.015_bib33","first-page":"1595","article-title":"Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia","volume":"119","author":"Kurian","year":"2009","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1474-4422(10)70269-6","article-title":"Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study","volume":"10","author":"Kurian","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib35","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1172\/JCI59373","article-title":"Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency","volume":"122","author":"Kurosawa","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1124\/mol.114.094045","article-title":"Chaperoning of the A1-adenosine receptor by endogenous adenosine - an extension of the retaliatory metabolite concept","volume":"87","author":"Kusek","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib37","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1212\/01.wnl.0000239153.39710.81","article-title":"High frequency of creatine deficiency syndromes in patients with unexplained mental retardation","volume":"67","author":"Lion-Fran\u00e7ois","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2019.03.015_bib38","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/cne.23667","article-title":"Distribution of the creatine transporter throughout the human brain reveals a spectrum of creatine transporter immunoreactivity","volume":"523","author":"Lowe","year":"2015","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib39","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neuroscience.2009.06.065","article-title":"Immunohistochemical localisation of the creatine transporter in the rat brain","volume":"163","author":"Mak","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2019.03.015_bib40","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ajmg.a.30473","article-title":"Two novel mutations in SLC6A8 cause creatine transporter defect and distinctive X-linked mental retardation in two unrelated Dutch families","volume":"132A","author":"Mancini","year":"2005","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib41","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1002\/ajmg.a.34208","article-title":"Creatine transporter defect diagnosed by proton NMR spectroscopy in males with intellectual disability","volume":"155A","author":"Mencarelli","year":"2011","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib42","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1523\/JNEUROSCI.2991-13.2014","article-title":"Axonal targeting of the serotonin transporter in cultured rat dorsal raphe neurons is specified by SEC24C-dependent export from the endoplasmic reticulum","volume":"34","author":"Montgomery","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib43","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/brain\/awu022","article-title":"Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood","volume":"137","author":"Ng","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2019.03.015_bib44","first-page":"49","article-title":"A family with creatine transporter deficiency diagnosed with urinary creatine\/creatinine ratio and the family history: the third Japanese familial case","volume":"47","author":"Nozaki","year":"2015","journal-title":"No Hattatsu"},{"key":"10.1016\/j.neuropharm.2019.03.015_bib45","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.parkreldis.2009.03.002","article-title":"A chemical chaperone, sodium 4-phenylbutyric acid, attenuates the pathogenic potency in human alpha-synuclein A30P + A53T transgenic mice","volume":"15","author":"Ono","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuroscience.2009.10.001","article-title":"Na(+)\/Cl(-)\/creatine transporter activity and expression in rat brain synaptosomes","volume":"165","author":"Peral","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2019.03.015_bib47","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jid.2016.10.035","article-title":"Functional rescue of ABCC6 deficiency by 4-phenylbutyrate therapy reduces dystrophic calcification in Abcc6-\/- mice","volume":"137","author":"Pomozi","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib48","doi-asserted-by":"crossref","first-page":"34048","DOI":"10.1074\/jbc.M702384200","article-title":"Modulation of epithelial sodium channel trafficking and function by sodium 4-phenylbutyrate in human nasal epithelial cells","volume":"282","author":"Pruli\u00e8re-Escabasse","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib49","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1124\/mol.104.001339","article-title":"Sodium 4-phenylbutyrate protects against cerebral ischemic injury","volume":"66","author":"Qi","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib50","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/npp.2008.229","article-title":"Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model","volume":"34","author":"Ricobaraza","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.03.015_bib51","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/hipo.20883","article-title":"Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease","volume":"22","author":"Ricobaraza","year":"2012","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2019.03.015_bib52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1086\/422102","article-title":"High prevalence of SLC6A8 deficiency in X-linked mental retardation","volume":"75","author":"Rosenberg","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib53","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/humu.20532","article-title":"Functional characterization of missense variants in the creatine transporter gene (SLC6A8): improved diagnostic application","volume":"28","author":"Rosenberg","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib54","doi-asserted-by":"crossref","first-page":"C259","DOI":"10.1152\/ajpcell.2000.278.2.C259","article-title":"Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of DeltaF508-CFTR","volume":"278","author":"Rubenstein","year":"2000","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib55","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ymgme.2005.08.004","article-title":"1H MR spectroscopy of the brain in Cr transporter defect","volume":"86","author":"Sijens","year":"2005","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib56","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/emboj.2013.79","article-title":"Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology","volume":"32","author":"Steentoft","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib57","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1042\/BJ20050857","article-title":"Effects of N-linked glycosylation on the creatine transporter","volume":"393","author":"Straumann","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib57a","doi-asserted-by":"crossref","first-page":"45083","DOI":"10.1074\/jbc.M111.293282","article-title":"4-Phenylbutyrate stimulates Hsp70 expression through the Elp2 component of elongator and STAT-3 in cystic fibrosis epithelial cells","volume":"286","author":"Suaud","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib58","doi-asserted-by":"crossref","first-page":"10924","DOI":"10.1074\/jbc.M109.083154","article-title":"The N terminus of monoamine transporters is a lever required for the action of amphetamines","volume":"285","author":"Sucic","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib59","doi-asserted-by":"crossref","first-page":"16482","DOI":"10.1074\/jbc.M111.230037","article-title":"The serotonin transporter is an exclusive client of the coat protein complex II (COPII) component SEC24C","volume":"286","author":"Sucic","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib60","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1074\/jbc.M112.408237","article-title":"Switching the clientele: a lysine residing in the C terminus of the serotonin transporter specifies its preference for the coat protein complex II component SEC24C","volume":"288","author":"Sucic","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib62","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3389\/fphys.2018.00773","article-title":"A mouse model of creatine transporter deficiency reveals impaired motor function and muscle energy metabolism","volume":"9","author":"Stockebrand","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib63","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1471-4159.2008.05652.x","article-title":"Expression and possible role of creatine transporter in the brain and at the blood-cerebrospinal fluid barrier as a transporting protein of guanidinoacetate, an endogenous convulsant","volume":"107","author":"Tachikawa","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib64","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1248\/bpb.b16-00582","article-title":"Abnormal N-glycosylation of a novel missense creatine transporter mutant, G561R, associated with cerebral creatine deficiency syndromes alters transporter activity and localization","volume":"40","author":"Uemura","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib65","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10545-011-9345-1","article-title":"Long-term follow-up and treatment in nine boys with X-linked creatine transporter defect","volume":"35","author":"van de Kamp","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neuropharm.2019.03.015_bib66","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/jmedgenet-2013-101658","article-title":"Phenotype and genotype in 101 males with X-linked creatine transporter deficiency","volume":"50","author":"van de Kamp","year":"2013","journal-title":"J. Med. Genet."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819301005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819301005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:58:20Z","timestamp":1758437900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390819301005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":60,"alternative-id":["S0028390819301005"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.03.015","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rescue by 4-phenylbutyrate of several misfolded creatine transporter-1 variants linked to the creatine transporter deficiency syndrome","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107572"}}